Dr Amir Khan shares how often to wash your hair to prevent hair loss - plus other tips
The way you care for your hair could be a factor in hair loss, according to Dr Amir Khan. (Source: Daily Express - Health)
Source: Daily Express - Health - June 1, 2023 Category: Consumer Health News Source Type: news
Does Ozempic Cause Hair Loss? Does Ozempic Cause Hair Loss?
Dermatologists and endocrinologists consider claims that new weight loss medications cause hair loss. They opine that hair loss is unlikely and is actually more common with bariatric surgery.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 25, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Article Source Type: news
Do Weight Loss Drugs Like Ozempic Cause Hair Loss?
Experts consider claims that new weight loss medications cause hair loss. They find that hair loss is unlikely and actually more common with bariatric surgery. (Source: WebMD Health)
Source: WebMD Health - May 24, 2023 Category: Consumer Health News Source Type: news
Changing the lives of patients with alopecia and vitiligo
Meet Dr. Brett King, the Yale dermatologist who advocated for the first FDA-approved treatments for these two life-altering conditions. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 22, 2023 Category: Universities & Medical Training Source Type: news
US Food and Drug Administration warning regarding finasteride and suicidal ideation: what should urologists know? - Al Saffar H, Xu J, O'Brien JS, Kelly BD, Murphy DG, Lawrentschuk N.
Finasteride competitively inhibits 5 α-reductase (5-AR) isoenzymes, which blocks dihydrotestosterone (DHT) production, thereby reducing DHT. Finasteride is used in the management of benign prostatic hyperplasia (BPH) and androgenic alopecia. Amid patient r... (Source: SafetyLit)
Source: SafetyLit - May 18, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Billions With Nutrition Deficiency!?
Almost no one gets enough selenium. Officially, at least a billion — with a B — people have a selenium deficiency.1
But I suspect the numbers are much higher than that.
You can’t get enough selenium from food alone anymore. That’s true even if you eat a healthy, varied diet. And you can thank Big Agra for that.
With their harsh pesticides, synthetic fertilizers, and single-crop strategy, these massive farms have stripped the nutrients out of the soil. No nutrients in the soil mean no nutrients in the food.
All of this makes it difficult — if not impossible — to get even some of the daily selenium you need to ...
Source: Al Sears, MD Natural Remedies - May 15, 2023 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Nutrition Source Type: news
People With Alopecia Have Higher Risk for Inflammatory Arthritis
MONDAY, May 15, 2023 -- Alopecia areata (AA) is associated with a higher risk for inflammatory arthritis, according to a study published online April 28 in the Journal of the American Academy of Dermatology.
Colin M. Kincaid, from University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2023 Category: Pharmaceuticals Source Type: news
New Hope Against Painful Skin Issues Caused by Cancer Radiation Therapy
MONDAY, May 8, 2023 -- When Ann Alexander underwent chemotherapy to treat breast cancer a decade ago, she was warned about potential hair loss, nausea and vomiting.
The 73-year-old wasn’t, however, told about the potential side effects of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 8, 2023 Category: General Medicine Source Type: news
FDA Puts Partial Hold on Investigational Alopecia Drug FDA Puts Partial Hold on Investigational Alopecia Drug
A pulmonary embolism occurred in a patient on the 12-mg dose, so testing was put on hold for that dose. There is no hold on the 8-mg dose.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 3, 2023 Category: Consumer Health News Tags: Dermatology News Source Type: news
US FDA halts Sun Pharma's trials on dermatological drug
The FDA has also said that patients with alopecia areata - an autoimmune condition that results in patchy hair loss - on the 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2023 Category: Pharmaceuticals Source Type: news
Expert warns of daily habits that could be causing hair loss - how to avoid
Many of us could be guilty of habits that can contribute to shedding hair, an expert has warned. (Source: Daily Express - Health)
Source: Daily Express - Health - April 22, 2023 Category: Consumer Health News Source Type: news
Women and Hair Loss: The Causes
WebMD talks to experts about the possible causes of hair loss in women. (Source: WebMD Health)
Source: WebMD Health - April 20, 2023 Category: Consumer Health News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Polivy in combination with R-CHP for people with certain types of previously untreated diffuse large B-cell lymphoma
Polivy combination is the first FDA-approved therapy in nearly 20 years for the first-line treatment of diffuse large B-cell lymphoma, an aggressive disease and the most common form of non-Hodgkin lymphoma in the USPOLARIX trial showed thePolivy combination reduced the risk of disease progression, relapse or death by 27% compared to the standard of care, R-CHOP, with a comparable safety profileFirst-line treatment withPolivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progressionBasel, 19 April 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that t...
Source: Roche Investor Update - April 19, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Polivy in combination with R-CHP for people with certain types of previously untreated diffuse large B-cell lymphoma
Polivy combination is the first FDA-approved therapy in nearly 20 years for the first-line treatment of diffuse large B-cell lymphoma, an aggressive disease and the most common form of non-Hodgkin lymphoma in the USPOLARIX trial showed thePolivy combination reduced the risk of disease progression, relapse or death by 27% compared to the standard of care, R-CHOP, with a comparable safety profileFirst-line treatment withPolivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progressionBasel, 19 April 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that t...
Source: Roche Media News - April 19, 2023 Category: Pharmaceuticals Source Type: news
